Finance

Lists
NTLX:CVE
Neurothera Labs Inc
CA$3.36
0.00%
(0.00) 1D
Sep 1, 3:05:13 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NTLX...
Mkt. cap
285.26M
Avg. vol.
2.81K
Volume
4.00
52-wk high
CA$5.32
52-wk low
CA$2.17
Beta
0.37
Shares outstanding
6.53M
Mkt. cap
285.26M
Avg. vol.
2.81K
Volume
4.00
52-wk high
CA$5.32
52-wk low
CA$2.17
Beta
0.37
Shares outstanding
6.53M
About Neurothera Labs Inc
CEO-
Employees-
Founded2021
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websiteneurothera.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
236.00K
159.00K
142.50K
142.50K
Cost of goods sold
70.00K
54.00K
36.00K
36.00K
Cost of revenue
70.00K
54.00K
36.00K
36.00K
Research and development expenses
-
1.80M
492.00K
492.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
260.00K
777.00K
731.50K
731.50K
Operating expense
260.00K
2.58M
1.22M
1.22M
Total operating expenses
330.00K
2.63M
1.26M
1.26M
Operating income
-94.00K
-2.47M
-1.12M
-1.12M
Other non operating income
-
-1.41M
-
-
EBT including unusual items
-94.00K
-4.08M
-1.10M
-1.10M
EBT excluding unusual items
-94.00K
-3.96M
-1.10M
-1.10M
Income tax expense
-
19.00K
-
-
Effective tax rate
-
-0.47%
-
-
Other operating expenses
-
-
-
-
Net income
-94.00K
-3.86M
-1.06M
-1.06M
Net profit margin
-39.83%
-2,427.04%
-744.91%
-744.91%
Earnings per share
-
-
-
-
Interest and investment income
-
43.00K
45.00K
45.00K
Interest expense
-
-125.00K
-23.00K
-23.00K
Net interest expenses
-
-82.00K
22.00K
22.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.00K
-2.42M
-1.07M
-1.07M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps